Answers are grounded in this paper and cite their sources.
// Beatrice Conti 1, * , Cristiana Porcu 2, * , Carmela Viscomi 1 , Antonella Minutolo 1, 3 , Susan Costantini 4 , Marco Corazzari 3 , Gino Iannucci 1 , Barbara Barbaro 2 , Clara Balsano 1, 2 1 Laboratory of Molecular Virology and Oncoloy, Francesco Balsano Foundation, ex A. Cesalpino Foundation, Rome, Italy 2 Institute of Biology and Molecular Pathology (IBPM) – CNR (National Research Council), Rome, Italy 3 Department of Biology, University of Rome ‘Tor Vergata’, Rome, Italy 4 CROM, Istituto Nazionale Tumori “Fondazione G.Pascale”, IRCSS, Napoli, Italy * These authors have contributed equally to this work Correspondence to: Clara Balsano, email: clara.balsano@cnr.it Keywords: HCV, liver steatosis, SHP1, NS5A, HCC Received: April 19, 2016 Accepted: August 20, 2016 Published: September 20, 2016 ABSTRACT HCV life cycle is strictly correlated with the hepatocyte lipid metabolism; moreover, the progression of HCV chronic hepatitis is accelerated by the presence of liver steatosis. Among the steatogenic genes deregulated during the HCV infection one of the most attractive is the Small Heterodimer Protein 1 (SHP1; NR0B2), that is involved in a remarkable number of metabolic functions. HCV NS5A is an essential and integral component of the HCV membranous-web replicon complex (RC) and plays an essential role to transfer the viral genome from the RCs to the surface of the lipid droplets (LDs) that, in turn, play a key function during HCV life cycle. With the help of a HCV infection model, we demonstrate a functional interaction between SHP1 and HCV NS5A protein. SHP1 silencing (siSHP1) reversed the pro-oncogenic effects of HCV infection, inducing a significant decrease in liver lipid accumulation and in NS5A protein expression. Moreover, siSHP1 causes a strong modulation of some genes involved in HCV-related EMT, such as: HNF4, a central regulators of hepatocyte differentiation, E-Cadherin, SNAILs. Our data suggest that SHP1 results not only to be strictly connected to the pathogenesis of HCV-related liver steatosis, but also to its progression towards the liver transformation.
No takes yet. Share an insight, caveat, or question.
Conti et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: